sIRB 101: An Introduction to Relying on an External IRB
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Single IRB (sIRB) review streamlines oversight for multisite trials, reducing administrative burdens while ensuring participant protections across all sites.
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
In the past few years, new regulations and policies have been announced and implemented to address the challenges of conducting clinical trials involving multiple research sites. Chief among these requirements is the use of a designated sIRB for multisite research.
On September 28, 2022, the Food and Drug Administration (FDA) released two proposed rules, or Notices of Proposed Rule Making
Multisite research and clinical trials increasingly rely on a single IRB (sIRB) for review. This increase reflects federal mandates, sponsor expectations, and the operational realities of modern multisite or cooperative research. For institutions with a local
CONSULTING & PROFESSIONAL SERVICES HRPP/IRB Advisory Services Advarra’s Human Research Protection Program (HRPP)/Institutional Review Board (IRB) Advisory services include accreditation
Welcome to Advarra’s Trust Center At Advarra, trust is the cornerstone of our relationships with clients, employees, and partners. Our
Advarra Innovation Summit Cambridge, MA June 11, 2025 | 8:30 am – 5:00 pm ETLe Méridien Boston Cambridge Explore the